Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolf C Mueller
Andreas von Deimling

Showing results (1-10 of 671) with videos related to

Pageof 68
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Gene regulation by methylationWolf C Mueller, Andreas von Deimling
Neuropathology and Applied Neurobiology|May 7, 2015
Diagnostic, prognostic and predictive relevance of molecular markers in gliomasSebastian Brandner, Andreas von Deimling
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Hereditary tumor syndromes and gliomasDavid Reuss, Andreas von Deimling
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Molecular pathology of oligodendroglial tumorsChristian Hartmann, Andreas von Deimling
Genes, Chromosomes & Cancer|April 7, 2022
Methylation classifiers: Brain tumors, sarcomas, and what's nextChristian Koelsche, Andreas von Deimling
Brain Pathology (Zurich, Switzerland)|December 7, 2010
The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutationsAndreas von Deimling, Andrey Korshunov, Christian Hartmann
Journal of Molecular Medicine (Berlin, Germany)|August 24, 2004
Pathology and molecular genetics of oligodendroglial tumorsChristian Hartmann, Wolf Mueller, Andreas von Deimling
Glia|February 5, 2011
Isocitrate dehydrogenase mutations: a challenge to traditional views on the genesis and malignant progression of gliomasMichael Weller, Wolfgang Wick, Andreas von Deimling
Clinical & Experimental Metastasis|March 16, 2007
Involvement of Hif-1 in desferrioxamine-induced invasion of glioblastoma cellsAnja Elstner, Nikola Holtkamp, Andreas von Deimling
Oncotarget|September 26, 2012
Mutation specific antibodies: tool or dinosaur?Andreas von Deimling, Felix Sahm, David Capper
Pageof 68

Showing results (1-10 of 671) with videos related to

Sort By:
Pageof 68
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Gene regulation by methylationWolf C Mueller, Andreas von Deimling
Neuropathology and Applied Neurobiology|May 7, 2015
Diagnostic, prognostic and predictive relevance of molecular markers in gliomasSebastian Brandner, Andreas von Deimling
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Hereditary tumor syndromes and gliomasDavid Reuss, Andreas von Deimling
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|March 27, 2009
Molecular pathology of oligodendroglial tumorsChristian Hartmann, Andreas von Deimling
Genes, Chromosomes & Cancer|April 7, 2022
Methylation classifiers: Brain tumors, sarcomas, and what's nextChristian Koelsche, Andreas von Deimling
Brain Pathology (Zurich, Switzerland)|December 7, 2010
The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutationsAndreas von Deimling, Andrey Korshunov, Christian Hartmann
Journal of Molecular Medicine (Berlin, Germany)|August 24, 2004
Pathology and molecular genetics of oligodendroglial tumorsChristian Hartmann, Wolf Mueller, Andreas von Deimling
Glia|February 5, 2011
Isocitrate dehydrogenase mutations: a challenge to traditional views on the genesis and malignant progression of gliomasMichael Weller, Wolfgang Wick, Andreas von Deimling
Clinical & Experimental Metastasis|March 16, 2007
Involvement of Hif-1 in desferrioxamine-induced invasion of glioblastoma cellsAnja Elstner, Nikola Holtkamp, Andreas von Deimling
Oncotarget|September 26, 2012
Mutation specific antibodies: tool or dinosaur?Andreas von Deimling, Felix Sahm, David Capper
Pageof 68